Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension - Concepedia

Concepedia

Publication | Open Access

Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension

DOI Full Paper Access

78

Citations

24

References

2019

Year

Ronald van Vollenhoven, Sandra Navarra, Roger A. Levy, Mathew Thomas, Amy Heath, Todd Lustine, Anthony Adamkovic, James Fettiplace, Mei‐Lun Wang, Beulah Ji,

Abstract

ClinicalTrials.gov, https://clinicaltrials.gov, NCT00424476 (BLISS-52), NCT00410384 (BLISS-76), NCT00732940 (BEL112232), NCT00712933 (BEL112234).

References

	Year	Citations
World Medical Association Declaration of Helsinki JAMA Biomedical EthicEthical PrinciplesResearch EthicsEthical PracticeMedical Tourism	2013	27.3K
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus Melissa R. Arbuckle, Micah T. McClain, Mark V. Rubertone, New England Journal of Medicine	2003	2.5K
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial Sandra Navarra, Renato Guzmán, A Gallacher, The Lancet RheumatologyAutoimmune DiseaseLupusSystemic TreatmentLupus Nephritis	2011	2K
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus Richard Furie, Michelle Petri, Omid Zamani, Arthritis & Rheumatism	2011	1.6K
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus Asmaa S. Abu Maziad, José Torrealba, Mouin G. Seikaly, Case Reports in Nephrology and Dialysis	2017	1.3K
Mortality in systemic lupus erythematosus Sasha Bernatsky, J.‐F. Boivin, L. Joseph, Arthritis & Rheumatism	2006	1.2K
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus Michelle Petri, Mimi Kim, Kenneth Kalunian, New England Journal of Medicine	2005	1.1K
Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus Jun Zhang, Viktor Roschke, Kevin P. Baker, The Journal of Immunology Humoral ResponseImmunologyB Cell ActivationPathologyImmunotherapy	2001	720
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort Ian N Bruce, Aidan G. O’Keeffe, Vernon T. Farewell, Annals of the Rheumatic Diseases	2014	537
Damage in systemic lupus erythematosus and its association with corticosteroids Abraham Zonana-Nacach, Susan G. Barr, Laurence S. Magder, Arthritis & Rheumatism	2000	485

Page 1